IOVA Stock Analysis: Buy, Sell, or Hold?
IOVA - Iovance Biotherapeutics, Inc. Common Stock
$3.45
-0.07 (-1.99%)
▼
5d:
-4.7%
30d:
-9.21%
90d:
+34.24%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
IOVA is down 4.7% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 7,009 OI. Call ratio: 74% View Scanner →
Strength: 4.7/10
Get Alerted When IOVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
19 traders called IOVA this week
93% bullish • 2 bearish
93% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IOVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IOVA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IOVA is currently trading at $3.45, which is considered slightly low relative to its 30-day fair value range of $3.39 to $3.82.
Technical Outlook: Technically, IOVA is in a uptrend. The price is currently testing key support at $3.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IOVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.80 (+155.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IOVA is in a uptrend. The price is currently testing key support at $3.38. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IOVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.80 (+155.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.39 -
$3.82
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 155.1% below Wall St target ($8.80)
Trading Range Analysis
30-Day Trading Range
$3.39 -
$3.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.38
Resistance Level
$4.15
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.33
Wall Street Target
$8.80
(+155.1%)
Revenue Growth (YoY)
44.8%
Profit Margin
-123.9%
Share & Embed Analysis
Last updated: May 18, 2026 8:00 AM ET
Data refreshes hourly during market hours. Next update: 9:00 AM
Data refreshes hourly during market hours. Next update: 9:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
